Drug
Anakinra Inj Syringe
Anakinra Inj Syringe: highest development phase Phase 2, developed by Swedish Orphan Biovitrum. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Swedish Orphan Biovitrum
Trials
| Drug | Phase | Indication |
|---|---|---|
| Anakinra 100Mg/0.67Ml Inj Syringe (Period 1) NCT03587701 | Phase 2 | Autoimmune Inner Ear Disease |
Latest
No recent events.
Follow Anakinra Inj Syringe on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.